UDI codes in orthoprosthetics SNS 2026: what manufacturers and dispensers must do

Key data

Manufacturers, distributors and orthoprosthetic dispensing points have new documentary obligations from July 14, 2026. The Order SND/715/2026 introduces the unique European product identifier (UDI) in the management of the supplementary orthoprosthetic benefit of the SNS, aligning with the Regulation EU 2017/745 on medical devices, which makes UDI mandatory since May 2025.

The regulation amends the Order SCB/45/2019 and the annex VI of Royal Decree 1030/2006, which regulates the portfolio of common services of the SNS. The change is not merely technical: it directly affects invoicing processes, traceability and management of the orthoprosthetic product catalog throughout the chain, from manufacturer to dispensing point.

What does this regulation establish?

Order SND/715/2026 introduces three structural changes in SNS orthoprosthetic management:

1. Mixed product identification system

A dual model is established that coexists during the transition period between the old directives system and the new Regulation EU 2017/745 framework:

2. New invoicing obligations

Dispensing establishments must register on each invoice:

• The UDI-DI code (for products certified under Regulation EU 2017/745)
• Or the product REF reference
• Together with the batch number or serial number of the dispensed product

3. Extension of the catalog renewal cycle

The orthoprosthetic catalog renewal period changes from 3 to 5 years, with the aim of rationalizing SNS administrative resources. The implementation of the new product offering is carried out progressively by sections, having started with the wheelchairs section in February 2025.

Alignment with the Recovery Plan

The regulation is framed within components C18.R3 and C18.I5 of the Recovery, Transformation and Resilience Plan, aimed at modernizing and digitalizing orthoprosthetic management in Spain.

Economic and operational impact

The main impact is not direct cost in fees or prices, but operational and compliance: dispensing establishments must adapt their invoicing and document management systems to incorporate the UDI-DI or REF together with the batch or serial number in each transaction.

For manufacturers and distributors, UDI was already mandatory since May 2025 under Regulation EU 2017/745, so this order transfers that obligation to the dispensing chain. Those who have not yet adapted their labeling and traceability systems have already accumulated a delay of more than a year with respect to the European framework.

The extension of the catalog renewal cycle from 3 to 5 years reduces the administrative burden on SNS managers, but also means that manufacturers must plan with longer horizons their strategies for inclusion or modification of products in the catalog.

Who does it affect?

• Manufacturers of orthoprosthetic products certified under Regulation EU 2017/745: obliged to incorporate the UDI-DI in their products since May 2025.
• Orthoprosthetic distributors: must ensure that the products they supply carry the correct UDI-DI code or REF reference.
• Dispensing establishments (orthopedic shops, clinics, SNS dispensing centers): obliged to register the UDI-DI or REF together with the batch or serial number on each invoice issued to the SNS.
• SNS managers and administrations: affected by the new catalog renewal cycle (5 years) and progressive implementation by sections.
• Manufacturers with products certified under previous directives: may maintain the seal or label system during their transitional periods, but must prepare the transition to UDI.

Practical example

An orthopedic shop that dispenses wheelchairs to the SNS (first section of the catalog implemented in February 2025) receives an order for a wheelchair certified under Regulation EU 2017/745. When issuing the invoice to the SNS, it is no longer sufficient to indicate the product description and price: it must mandatorily include the UDI-DI code of the specific model and the serial number of the dispensed unit.

If that same orthopedic shop also dispenses an upper limb orthosis certified under a previous directive and still in transitional period, it can continue using the seal or label system on the invoice, without needing to incorporate the UDI-DI until that transitional period ends.

This mixed scenario requires that dispensing establishments precisely identify what certification each product in their catalog has in order to apply the correct identification system on each invoice.

What should companies do now?

1. Audit the product catalog: identify which products are certified under Regulation EU 2017/745 (and therefore already require UDI-DI on invoice) and which still fall under previous directives in transitional period.
2. Adapt the invoicing system: ensure that management software allows including the UDI-DI or REF field together with the batch or serial number on invoices issued to the SNS.
3. Coordinate with manufacturers and distributors: verify that supplied products carry the correctly assigned UDI-DI and that the information is available for registration on invoice.
4. Plan the complete transition to UDI: although products under previous directives have transitional margin, already prepare processes for when that period ends and UDI becomes universal.
5. Review catalog strategy: with the new 5-year renewal cycle (previously 3), adjust plans for inclusion or modification of products in the SNS orthoprosthetic catalog.
6. Follow progressive implementation: the catalog is deployed by sections (started with wheelchairs in February 2025). Stay alert to when the sections affecting your own products are activated.

Official source

Consult complete regulation in official source

Notice: This article is purely informational in nature and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-15302